JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank50
5Y CAGR-22.7%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

5Y CAGR
-22.7%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202510.38%
202447.02%
2023-21.12%
2022-53.06%
202115.64%
202037.58%
2019-13.94%
20182.74%
201716.13%
201639.46%